Fondaparinux or Enoxaparin for the Initial Treatment of Symptomatic Deep Venous Thrombosis

Abstract

Once-daily subcutaneous fondaparinux was at least as effective (not inferior) and safe as twice-daily, body weight-adjusted enoxaparin in the initial treatment of patients with symptomatic deep venous thrombosis.